| Jerome Pierson, MD | |
|
801 5th St, Ste 410, Sioux City, IA 51102-1394 | |
| (712) 239-4702 | |
| (712) 239-0616 |
| Full Name | Jerome Pierson |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 39 Years |
| Location | 801 5th St, Sioux City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659345668 | NPI | - | NPPES |
| 0080952 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25565 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Regional Medical Center | Sioux city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Iowa Hospital Corporation | 0749198026 | 46 |
News Archive
Researchers at the University of California, San Diego School of Medicine say antibodies to a non-human sugar molecule commonly found in people may be useful as a future biomarker for predicting cancer risk, for diagnosing cancer cases early and, in sufficient concentration, used as a treatment for suppressing tumor growth.
The drug industry and teaching hospitals are among the health industry sectors that are bracing for hits from the budget deal. Meanwhile, other health care providers are watching and waiting - trying to figure out what might become of their interests as the negotiations go forward. And Democrats and liberal advocates, the staunchest supporters of the health law, fear President Barack Obama could give up too much in the ultimate agreement.
3M Drug Delivery Systems announces the signing of a non-exclusive license agreement with the Infectious Disease Research Institute (IDRI) in support of vaccine research for humanitarian efforts in developing countries. Under the agreement, 3M will donate its patented toll-like receptor (TLR) immune response modifier compounds.
TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 will be presented at the annual meeting of the American Society of Clinical Oncology on June 5-7, 2010 in Chicago, IL.
In March 2020, when the pandemic hit, everything slowed, including non-essential medical procedures such as elective surgeries, to reduce the spread of the coronavirus.
› Verified 8 days ago
| Entity Name | Northwest Iowa Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215962550 PECOS PAC ID: 0749198026 Enrollment ID: O20040217000619 |
News Archive
Researchers at the University of California, San Diego School of Medicine say antibodies to a non-human sugar molecule commonly found in people may be useful as a future biomarker for predicting cancer risk, for diagnosing cancer cases early and, in sufficient concentration, used as a treatment for suppressing tumor growth.
The drug industry and teaching hospitals are among the health industry sectors that are bracing for hits from the budget deal. Meanwhile, other health care providers are watching and waiting - trying to figure out what might become of their interests as the negotiations go forward. And Democrats and liberal advocates, the staunchest supporters of the health law, fear President Barack Obama could give up too much in the ultimate agreement.
3M Drug Delivery Systems announces the signing of a non-exclusive license agreement with the Infectious Disease Research Institute (IDRI) in support of vaccine research for humanitarian efforts in developing countries. Under the agreement, 3M will donate its patented toll-like receptor (TLR) immune response modifier compounds.
TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 will be presented at the annual meeting of the American Society of Clinical Oncology on June 5-7, 2010 in Chicago, IL.
In March 2020, when the pandemic hit, everything slowed, including non-essential medical procedures such as elective surgeries, to reduce the spread of the coronavirus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jerome Pierson, MD Po Box 3128, Sioux City, IA 51102-3128 Ph: (712) 239-4702 | Jerome Pierson, MD 801 5th St, Ste 410, Sioux City, IA 51102-1394 Ph: (712) 239-4702 |
News Archive
Researchers at the University of California, San Diego School of Medicine say antibodies to a non-human sugar molecule commonly found in people may be useful as a future biomarker for predicting cancer risk, for diagnosing cancer cases early and, in sufficient concentration, used as a treatment for suppressing tumor growth.
The drug industry and teaching hospitals are among the health industry sectors that are bracing for hits from the budget deal. Meanwhile, other health care providers are watching and waiting - trying to figure out what might become of their interests as the negotiations go forward. And Democrats and liberal advocates, the staunchest supporters of the health law, fear President Barack Obama could give up too much in the ultimate agreement.
3M Drug Delivery Systems announces the signing of a non-exclusive license agreement with the Infectious Disease Research Institute (IDRI) in support of vaccine research for humanitarian efforts in developing countries. Under the agreement, 3M will donate its patented toll-like receptor (TLR) immune response modifier compounds.
TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 will be presented at the annual meeting of the American Society of Clinical Oncology on June 5-7, 2010 in Chicago, IL.
In March 2020, when the pandemic hit, everything slowed, including non-essential medical procedures such as elective surgeries, to reduce the spread of the coronavirus.
› Verified 8 days ago
Sharon K Fey, PA C Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 700 4th Street, Ste 410, Sioux City, IA 51101 Phone: 712-255-7746 Fax: 712-255-0829 | |
Joy L Taylor, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5885 Sunnybrook Dr, Suite L-200, Sioux City, IA 51106 Phone: 712-239-4702 Fax: 712-224-5898 | |
Dr. Peter Jon Anderson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 801 5th St, Sioux City, IA 51101 Phone: 712-279-2010 Fax: 712-279-2034 | |
Dr. Robert Mark Stewart, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2730 Pierce St, Suite 401, Sioux City, IA 51104 Phone: 712-255-8827 Fax: 712-255-4862 | |
William R Wanner, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5885 Sunnybrook Dr, Suite L-200, Sioux City, IA 51106 Phone: 712-239-4702 Fax: 712-224-5898 | |
Roque Bernardo Arteaga, M.D., FACC Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5885 Sunnybrook Dr, Suite L-200, Sioux City, IA 51106 Phone: 712-239-4702 Fax: 712-224-5898 | |
Dr. Olusola Ogundipe, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 801 5th St, Sioux City, IA 51101 Phone: 712-279-2010 |